-
公开(公告)号:EP1219600A1
公开(公告)日:2002-07-03
申请号:EP00951967.9
申请日:2000-08-11
发明人: SATO, Fumie , TANAMI, Tohru, c/o Taisho Pharmaceutical Co Ltd , TANAKA, Hideo, c/o Taisho Pharmaceutical Co Ltd , ONO, Naoya, c/o Taisho Pharmaceutical Co Ltd , YAGI, Makoto, c/o Taisho Pharmaceutical Co Ltd
IPC分类号: C07C405/00 , A61K31/5575 , A61P13/12 , A61P9/10 , A61P9/04 , A61P9/12 , A61P25/20
CPC分类号: C07C405/00
摘要: A prostaglandin derivative represented by the formula:
wherein X is a halogen atom, R 1 is a hydrogen atom, a C 1-10 alkyl group or a C 3-10 cycloalkyl group, m is an integer of 0 to 5, and Y is a group represented by the formula:
wherein R 2 is a C 3-10 cycloalkyl group, a C 3-10 cycloalkyl group substituted with C 1-4 alkyl group(s), a C 1-4 alkyl group substituted with C 3-10 cycloalkyl group(s), a C 1-10 alkyl group, a C 2-10 alkenyl group, a C 2-10 alkynyl group or a bridged cyclic hydrocarbon group, or a group represented by the formula:
wherein n is an integer of 1 to 8; a pharmaceutically acceptable salt thereof or a hydrate thereof.摘要翻译: 由下式表示的前列腺素衍生物:
其中X为卤素原子,R 1为氢原子,C 1-10烷基或C 3-10环烷基,m为0-5的整数, Y为由下式表示的基团:其中R 2为C 3-10环烷基,被C 1-4烷基取代的C 3-10环烷基,C 1-4烷基取代 具有C 3-10环烷基,C 1-10烷基,C 2-10烯基,C 2-10炔基或桥连环烃基,或由下式表示的基团:其中n 是1〜8的整数, 其药学上可接受的盐或其水合物。 -
公开(公告)号:EP1211242B1
公开(公告)日:2010-01-13
申请号:EP00957064.9
申请日:2000-09-08
发明人: SATO, Fumie , TANAMI, Tohru, c/o Taisho Pharmaceutical Co Ltd , TANAKA, Hideo, c/o Taisho Pharmaceutical Co Ltd , ONO, Naoya, c/o Taisho Pharmaceutical Co Ltd , YAGI, Makoto, c/o Taisho Pharmaceutical Co Ltd , HIRANO, Hitomi, c/o Taisho Pharmaceutical Co Ltd
IPC分类号: C07C405/00 , A61K31/5575 , A61P9/10 , A61P27/06 , A61P25/20 , A61P43/00
CPC分类号: C07C405/00 , C07C405/0016
摘要: Prostaglandin derivatives of general formula (I), pharmaceutically acceptable salts thereof, or hydrates of both: [wherein X is α a- or β-substituent halogeno; Y is ethylene, vinylene, or ethynylene; A is O(CH2)n, S(O)p(CH2)n, O(CH2)qO(CH2)r, O(CH2)qS(O)p(CH2)r, S(O)p(CH2)qS(O)p(CH2)r, or S(O)p(CH2)qO(CH2)r (wherein n is an integer of 1 to 5; p is 0, 1 or 2; q is an integer of 1 to 3; and r is 0 or 1); R1 is C¿3-10? cycloalkyl, C1-4 alkyl C3-10 cycloalkyl, C3-10 cycloalkyl C1-4 alkyl, C5-10 alkyl, C5-10 alkenyl, C5-10 alkynyl, or a bridged cyclic hydrocarbon group; R?2¿ is H, C¿1-10? alkyl, or C3-10 cycloalkyl; and m is 0, 1 or 2]. These compounds are novel and exhibit excellent prostaglandin D2-like agonism and a sleep-inducing effect.
-
公开(公告)号:EP1211242A1
公开(公告)日:2002-06-05
申请号:EP00957064.9
申请日:2000-09-08
发明人: SATO, Fumie , TANAMI, Tohru, c/o Taisho Pharmaceutical Co Ltd , TANAKA, Hideo, c/o Taisho Pharmaceutical Co Ltd , ONO, Naoya, c/o Taisho Pharmaceutical Co Ltd , YAGI, Makoto, c/o Taisho Pharmaceutical Co Ltd , HIRANO, Hitomi, c/o Taisho Pharmaceutical Co Ltd
IPC分类号: C07C405/00 , A61K31/5575 , A61P9/10 , A61P27/06 , A61P25/20 , A61P43/00
CPC分类号: C07C405/00 , C07C405/0016
摘要: A prostaglandin derivative represented by the formula:
wherein X is a halogen atom in the α- or β-position, Y is an ethylene group, a vinylene group or an ethynylene group, A is a group represented by the formula: O(CH 2 ) n ,
S(O) p (CH 2 ) n ,
O(CH 2 ) q O(CH 2 ) r ,
O(CH 2 ) q S(O) p (CH 2 ) r ,
S(O) p (CH 2 ) q S(O) p (CH 2 ) r
or
S(O) p (CH 2 ) q O(CH 2 ) r
(wherein n is an integer of 1 to 5, p is 0, 1 or 2, q is an integer of 1 to 3, and r is 0 or 1),
R 1 is a C 3-10 cycloalkyl group, a C 1-4 alkyl-C 3-10 cycloalkyl group, a C 3-10 cycloalkyl-C 1-4 alkyl group, a C 5-10 alkyl group, a C 5-10 alkenyl group, a C 5-10 alkynyl group or a bridged cyclic hydrocarbon group,
R 2 is a hydrogen atom, a C 1-10 alkyl group or a C 3-10 cycloalkyl group, and
m is 0, 1 or 2], a pharmaceutically acceptable salt thereof or a hydrate thereof.
The present invention is to provide novel PG derivatives having an excellent PGD 2 -like agonistic activity and a sleep-inducing action.摘要翻译: 由下式表示的前列腺素衍生物:其中X是α-位或β-位的卤素原子,Y是亚乙基,亚乙烯基或亚乙炔基,A是由下式表示的基团:O (CH2)n,S(O)p(CH2)n,O(CH2)qO(CH2)r,O(CH2)qS(O)p(CH2)r,S(O)p(CH2)qS )p(CH 2)r或S(O)p(CH 2)q O(CH 2)r(其中n为1〜5的整数,p为0,1或2,q为1〜3的整数,r 是0或1),R 1是C 3-10环烷基,C 1-4烷基-C 3-10环烷基,C 3-10环烷基-C 1-4烷基,C 5-10烷基, C5-10烯基,C5-10炔基或桥连环烃基,R 2为氢原子,C1-10烷基或C3-10环烷基,m为0,1或2Ü ,其药学上可接受的盐或其水合物。 本发明提供具有优异的PGD 2样激动活性和睡眠诱导作用的新型PG衍生物。
-
-